NO993825L - Formulering av stabiliserte, kationiske transfeksjonsmidler/nukleinsyrepartikler - Google Patents

Formulering av stabiliserte, kationiske transfeksjonsmidler/nukleinsyrepartikler

Info

Publication number
NO993825L
NO993825L NO993825A NO993825A NO993825L NO 993825 L NO993825 L NO 993825L NO 993825 A NO993825 A NO 993825A NO 993825 A NO993825 A NO 993825A NO 993825 L NO993825 L NO 993825L
Authority
NO
Norway
Prior art keywords
nucleic acid
formulation
acid particles
transfection agents
cationic transfection
Prior art date
Application number
NO993825A
Other languages
English (en)
Norwegian (no)
Other versions
NO993825D0 (no
Inventor
Joul Crouzet
Bruno Pitard
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9503492&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO993825(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of NO993825L publication Critical patent/NO993825L/no
Publication of NO993825D0 publication Critical patent/NO993825D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO993825A 1997-02-10 1999-08-09 Formulering av stabiliserte, kationiske transfeksjonsmidler/nukleinsyrepartikler NO993825D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9701467A FR2759298B1 (fr) 1997-02-10 1997-02-10 Formulation de particules agent(s) de transfection cationique(s)/acides nucleiques stabilisees
PCT/FR1998/000222 WO1998034648A1 (fr) 1997-02-10 1998-02-06 Formulation de particules agent(s) de transfection cationique(s)/acides nucleiques stabilisees

Publications (2)

Publication Number Publication Date
NO993825L true NO993825L (no) 1999-08-09
NO993825D0 NO993825D0 (no) 1999-08-09

Family

ID=9503492

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993825A NO993825D0 (no) 1997-02-10 1999-08-09 Formulering av stabiliserte, kationiske transfeksjonsmidler/nukleinsyrepartikler

Country Status (20)

Country Link
EP (1) EP1007097B1 (de)
JP (1) JP2001511171A (de)
KR (1) KR20000070914A (de)
AT (1) ATE206932T1 (de)
AU (1) AU737720B2 (de)
BR (1) BR9807563A (de)
CA (1) CA2278665A1 (de)
CZ (1) CZ282199A3 (de)
DE (1) DE69802102T2 (de)
DK (1) DK1007097T3 (de)
ES (1) ES2166146T3 (de)
FR (1) FR2759298B1 (de)
GR (1) GR3036919T3 (de)
HU (1) HUP0001720A3 (de)
IL (1) IL130765A0 (de)
NO (1) NO993825D0 (de)
PT (1) PT1007097E (de)
SK (1) SK282685B6 (de)
WO (1) WO1998034648A1 (de)
ZA (1) ZA981034B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6359054B1 (en) * 1994-11-18 2002-03-19 Supratek Pharma Inc. Polynucleotide compositions for intramuscular administration
AU768542C (en) * 1998-04-08 2004-06-17 Celltech R & D Limited Lipids
WO2000003683A2 (en) * 1998-07-20 2000-01-27 Inex Pharmaceuticals Corporation Liposomal encapsulated nucleic acid-complexes
CA2401239A1 (en) * 2000-03-03 2001-09-13 Valentis, Inc. Improved poloxamer and poloxamine compositions for nucleic acid delivery
GB0009201D0 (en) * 2000-04-14 2000-05-31 Univ Nottingham Cationic polymer - Nucleic acid complexes and methods of making them
US20020091242A1 (en) 2000-10-11 2002-07-11 Michel Bessodes Acid-sensitive compounds, their preparation and uses
ATE503463T1 (de) * 2000-10-20 2011-04-15 Vical Inc Gen-abgabeformulierungen zur behandlung ischämischer zustände
EP1232758A1 (de) * 2001-02-19 2002-08-21 Aventis Pasteur Polynukleotid-Formulierung für verbesserte intrazellulare Übertragung
US8092788B2 (en) 2004-03-03 2012-01-10 Revance Therapeutics, Inc. Compositions and methods for topical diagnostic and therapeutic transport
US9211248B2 (en) 2004-03-03 2015-12-15 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
EP1861112A4 (de) 2005-03-03 2009-07-22 Revance Therapeutics Inc Zusammensetzungen und verfahren zur topischen anwendung und transdermalen abgabe von botulinumtoxinen
JP4653242B1 (ja) 2010-02-12 2011-03-16 ナノキャリア株式会社 粒子状医薬組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1181937A3 (de) * 1994-08-09 2004-02-04 Cytrx Corporation Nukleinsäure enthaltender Impfstoff, Impfstoff-adjuvans
AU5527696A (en) * 1995-03-31 1996-10-16 Children's Hospital Medical Center Use of surfactants for introducing genetic material into lun g cells
US6120794A (en) * 1995-09-26 2000-09-19 University Of Pittsburgh Emulsion and micellar formulations for the delivery of biologically active substances to cells

Also Published As

Publication number Publication date
CA2278665A1 (fr) 1998-08-13
EP1007097B1 (de) 2001-10-17
HUP0001720A3 (en) 2001-10-29
HUP0001720A1 (hu) 2000-09-28
DE69802102D1 (de) 2001-11-22
WO1998034648A1 (fr) 1998-08-13
KR20000070914A (ko) 2000-11-25
BR9807563A (pt) 2000-02-01
SK282685B6 (sk) 2002-11-06
DK1007097T3 (da) 2002-02-11
AU6298798A (en) 1998-08-26
NO993825D0 (no) 1999-08-09
JP2001511171A (ja) 2001-08-07
IL130765A0 (en) 2001-01-28
ZA981034B (en) 1998-08-11
SK108299A3 (en) 2000-05-16
FR2759298B1 (fr) 1999-04-09
ATE206932T1 (de) 2001-11-15
CZ282199A3 (cs) 1999-10-13
AU737720B2 (en) 2001-08-30
PT1007097E (pt) 2002-04-29
ES2166146T3 (es) 2002-04-01
EP1007097A1 (de) 2000-06-14
FR2759298A1 (fr) 1998-08-14
GR3036919T3 (en) 2002-01-31
DE69802102T2 (de) 2002-03-14

Similar Documents

Publication Publication Date Title
NO993825D0 (no) Formulering av stabiliserte, kationiske transfeksjonsmidler/nukleinsyrepartikler
IL172835A0 (en) A composition for stabilizing active protein ingredients in pharmaceutical composition containing at least 2 amino acids
EP0911039A3 (de) Wirkstoff-Harzkomplexe stabilisiert mit Chelatbildner
PT1123120E (pt) Formulacao medicinal em aerossol
ATE383169T1 (de) Komponente und zusammensetzungen zur verabreichung von wirkstoffen
BR9509496A (pt) Composições farmacêuticas
HK1028548A1 (en) Formulations for hydrophobic pharmaceutical agents
BR9906916A (pt) Composição de revestimento em pó
WO2000032186A3 (en) Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
AR028727A1 (es) Una composicion detergente liquida
AU3868997A (en) Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
IT1314185B1 (it) Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
BE1014502A5 (fr) Compositions pharmaceutiques.
MXPA04001007A (es) Emulsion inversa que contiene dihidroepiandrosterona.
ATE245028T1 (de) Trimegestone enthaltende pharmazeutische zusammensetzungen
WO2002017956A3 (en) Stabilized fgf formulations containing reducing agents
BR9811985A (pt) Dispositivo de dosagem
WO2002083891A3 (en) Nucleic acids for inhibiting hairless protein expression and methods of use thereof
PH11997055419B1 (en) Cleansing composition comprising color stabilizer(s) and surfactant(s)
GB2349335A (en) Compositions
HUP0202378A3 (en) Surfactant mixture, emulsion containing thereof structured surfactant composition and detergent composition
WO1998023260A3 (en) Non-ionic surfactant vesicles as a delivery agent for nucleic acid
EP0891778A3 (de) Mittel für Vorbeugung und/oder Behandlung von strahlungsinduzierter Störungen
Kamioka Dynamics and kinetics of oxidation of semiconductor surfaces
MX9603741A (es) Composicion de liberacion mantenida.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application